CVE-2023-1968: Illumina iScan Firmware SSRF Vulnerability

CVE-2023-1968 Overview

CVE-2023-1968 is an insecure default configuration vulnerability affecting Illumina Universal Copy Service (UCS) v2.x deployed across multiple Illumina DNA sequencing instruments. The vulnerability stems from UCS binding to an unrestricted IP address (0.0.0.0), which allows the service to listen on all network interfaces including those accessible from remote networks. An unauthenticated malicious actor could exploit this misconfiguration to intercept or access sensitive genomic data transmitted through the service without requiring any authentication credentials.

Critical Impact

Unauthenticated remote attackers can access sensitive genomic and research data on affected Illumina sequencing instruments via network-accessible Universal Copy Service, potentially compromising patient privacy and research integrity in healthcare and laboratory environments.

Affected Products

• Illumina iScan (Firmware 4.0.0, 4.0.5)
• Illumina iSeq 100 (All firmware versions with UCS v2.x)
• Illumina MiniSeq (All firmware versions with UCS v2.x)
• Illumina MiSeq (All firmware versions with UCS v2.x)
• Illumina MiSeqDx (Firmware 4.0 and IVD versions)
• Illumina NextSeq 500 (Firmware 4.0)
• Illumina NextSeq 550 (Firmware 4.0)
• Illumina NextSeq 550Dx (Multiple firmware versions)
• Illumina NextSeq 1000 (Firmware 1.4.1)
• Illumina NextSeq 2000 (Firmware 1.4.1)
• Illumina NovaSeq 6000 (Firmware 1.8 and earlier)

Discovery Timeline

• April 28, 2023 - CVE-2023-1968 published to NVD
• November 21, 2024 - Last updated in NVD database

Technical Details for CVE-2023-1968

Vulnerability Analysis

This vulnerability is classified under CWE-1327 (Binding to an Unrestricted IP Address), which represents a fundamental security misconfiguration in network service deployment. The Illumina Universal Copy Service v2.x is designed to facilitate data transfer operations on sequencing instruments, but its default configuration binds to all available network interfaces rather than restricting access to localhost or specific trusted interfaces.

The impact of this vulnerability is particularly concerning in healthcare and research environments where Illumina sequencing instruments process sensitive genomic data. When UCS binds to 0.0.0.0, any device on the same network segment—or potentially across routed networks if firewall rules permit—can connect to the service. Since no authentication is required, attackers can leverage this access to exfiltrate confidential sequencing data, monitor ongoing operations, or potentially interfere with data transfer processes.

Root Cause

The root cause of CVE-2023-1968 lies in the insecure default configuration of the Universal Copy Service v2.x software component. Rather than binding to the loopback interface (127.0.0.1) or requiring explicit configuration of allowed interfaces, the service defaults to binding on all available network interfaces (0.0.0.0). This design decision prioritizes ease of deployment over security, leaving instruments vulnerable when connected to networks without adequate segmentation or perimeter controls.

Attack Vector

The attack vector for this vulnerability is network-based and requires no authentication or user interaction. An attacker with network access to an affected Illumina instrument can connect directly to the Universal Copy Service endpoint. The service accepts connections from any IP address, enabling unauthorized access to data in transit. In laboratory or healthcare environments where instruments may be connected to clinical or research networks, this could allow attackers to intercept sensitive patient genomic data or proprietary research information.

The exploitation scenario involves network reconnaissance to identify Illumina instruments running vulnerable UCS versions, followed by direct connection to the exposed service port. Since the service lacks authentication controls, the attacker immediately gains access to the data transfer functionality without needing to bypass any security mechanisms.

Detection Methods for CVE-2023-1968

Indicators of Compromise

• Unexpected network connections to Illumina sequencing instruments from unauthorized IP addresses
• Unusual data transfer patterns or volumes from sequencing instrument network interfaces
• Network traffic to/from UCS service ports originating from non-whitelisted sources
• Log entries showing connections from external or unknown network segments to UCS endpoints

Detection Strategies

• Deploy network monitoring to detect connections to Illumina instruments from unexpected source IP addresses
• Implement firewall rules with logging to track all inbound connections to sequencing instrument network segments
• Configure IDS/IPS signatures to alert on traffic patterns consistent with UCS protocol communications from untrusted sources
• Conduct regular network scans to identify services bound to 0.0.0.0 on laboratory and healthcare network segments

Monitoring Recommendations

• Establish baseline network behavior for Illumina instruments and alert on deviations
• Monitor for port scanning activity targeting sequencing instrument subnets
• Review UCS service logs for connection attempts from unauthorized IP ranges
• Implement network flow analysis to detect data exfiltration patterns from instrument networks

How to Mitigate CVE-2023-1968

Immediate Actions Required

• Isolate affected Illumina instruments on dedicated network segments with strict access controls
• Implement firewall rules to restrict inbound connections to UCS service ports to authorized management systems only
• Conduct an inventory of all Illumina sequencing instruments to identify those running vulnerable UCS v2.x versions
• Review network architecture to ensure sequencing instruments are not directly accessible from untrusted networks

Patch Information

Illumina has released updated software to address this vulnerability. Organizations should download and apply the latest Illumina Universal Copy Service from the Illumina Universal Copy Service Download page. Additionally, CISA has published a medical advisory (ICSMA-23-117-01) providing detailed remediation guidance for healthcare organizations operating affected instruments.

Contact Illumina technical support for instrument-specific firmware update procedures and verify compatibility before deploying updates in production environments.

Workarounds

• Configure host-based firewalls on instrument operating systems to restrict UCS service access to localhost or specific management IP addresses
• Deploy network segmentation to isolate sequencing instruments from general-purpose networks
• Implement network access control (NAC) to restrict which devices can communicate with instrument subnets
• Use VPN or jump host architectures for remote management of sequencing instruments rather than direct network exposure

# Example network segmentation firewall rule (iptables)
# Restrict access to UCS service port to authorized management subnet only
iptables -A INPUT -p tcp --dport <UCS_PORT> -s 10.0.1.0/24 -j ACCEPT
iptables -A INPUT -p tcp --dport <UCS_PORT> -j DROP

# Log unauthorized connection attempts for monitoring
iptables -A INPUT -p tcp --dport <UCS_PORT> -j LOG --log-prefix "UCS-UNAUTHORIZED: "